Please login to the form below

Not currently logged in
Email:
Password:

Tiziana Life Sciences appoints clinical sciences VP

Dr Robert Evans joins the UK biotechnology firm

London-based Tiziana Life Sciences has appointed Dr Robert Evans as its new vice president of clinical sciences.

Dr Evans joins the clinical stage biotechnology company from Glenmark Pharmaceuticals, where he also served as vice president of clinical sciences.

In that role, he was responsible for providing project and clinical leadership across multiple programmes focused on the treatment of oncology, respiratory and dermatology disorders.

Prior to this, Dr Evans held a number of scientific leadership positions while at Amgen, Johnson & Johnson and Regeneron.

James Tripp, chief operating officer at Tiziana Life Sciences, said: “Bob's extensive background in the clinical development industry… combined with his strong background in immunology and oncology adds tremendous support to our exciting portfolio.

“I am very confident that together with out impressive pipeline and strong team we will continue to drive the company forward to significant future success.”

6th May 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics